Humanigen Inc (HGENQ)

[Fezziwig2008]

From Fauci’s NIAID BET - “Lenzilumab is a first-in-class recombinant monoclonal antibody targeting soluble human GM-CSF, with potential immunomodulating activity, high binding affinity in the pM range, and 94% specificity to the human germline, which reduces immunogenicity.”
$HGEN seems to sound promising to the #1 COVID Federal Agency - why it was the only GM-CSF mAb picked by Fauci over $KNSA $CYDY and Roivant.


https://clinicaltrials.gov/ct2/show/NCT04583969?term=Lenzilumab&draw=2&rank=4